chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Kinda warm; son draw a sign arround the redness and grow along the borderline during the night; Redness; Swelling; Tender; A spontaneous report was received from a Nurse, concerning about 58-year-old, female patient who received Moderna's Covid-19 Vaccine (mRNA-1273) and experienced redness/injection site erythema, swelled/injection site swelling, tender/injection site pain, warm/injection site warmth and swelling/injection site swelling.  The patient's medical history was not reported. Concomitant medications were included Aveeno cream.   On 29 Dec 2020, the patient received their first dose of two planned doses of mRNA-1273 (Batch number: unknown) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.   On 06 Jan 2021, the patient reported she had redness, swelling, tenderness, warmth and swelling at the injection site. The patient's son drew a circle around the swelling. The patient had an appointment with her doctor who prescribed clotrimazole cream.   Action taken with Moderna's COVID-19 Vaccine was reported as unknown.  The outcome of the events redness/injection site erythema, swelled/injection site swelling, tender/injection site pain, warm/injection site warmth and swelling/injection site swelling, were reported as unknown.; Reporter's Comments: This case concerns a 58-year-old female who had NS unexpected injection site inflammation and injection site warmth and NS expected injection site erythema, injection site pain, injection site swelling.  Event onset occurred 1 days after the first dose of mRNA-1273. Treatment with clotrimazole cream. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient is fully vaccinated for COVID-19, one dose documented 01/07/2021, date of other isn't documented.  78 YO F with PMHx dementia, chronic anemia, GERD, hypothyroidism, depression sent to the ED from nursing facility for ALOC.  She was seen at this hospital yesterday for 2 days of insomnia, increased agitation, at which time her work-up was unremarkable.  She was D/C back to nursing facility and then returned today for persistent AMS.  She was Dx with COVID in the ED and will be admitted to COVID medical floor since she is medically stable...On 9/7 I called patients' relative, who is the POA, informed him of the patient's poor prognosis, and he agreed to switch the patient to comfort care.
After vaccination, complained of tingling on lips and tongue.  Legs felt heavy; fatigued.  Treated with PO Benadryl and observed by onsite RN and paramedic- much improved.  Follow-up call to patient 24 hours later and she is feeling much better.
I had fever of  103, chills, body ache, headache , rash across face from fever, really sore arm, fatigue .
Child was at daycare. He took a longer than average afternoon nap and woke up a little warm. He was standing at the window with his caregiver when his eyes rolled back and he appeared to loose consciousness. Cyanotic around lips, shaking. No tonic/clonic movements. Lasted 2 minutes. Transported to ER via ambulance. Temp on arrival 104.3 degrees.
Patient received Fluzone and Pneumovax vaccines on 10/19/07. Patient informed us on 10/22/07 that she usually gets sick a little when she gets her flu shot, but starting 1-2 days after receiving vaccines, her normal temp of 97 went to 101, arm hurt, redness, pain down to palm of hand. She went to chiropractor for an adjustment and took APAP. Used ice.
pt broke out w/a measles-like rash on 15AUG95 @ approx 12PM;by evening pt was completely covered head to toe w/hive-like rash;c/o flu-like sx, fatigue, dec appetite, & nausea but was afeb;16AUG95 rash noticeably resolved w/only redness
Family notified healthcare professional on 10/18/2021 that patient died on 10/18/2021
Nausea, muscle aches, fever, extremely sore left arm (not resolved yet).
Second injection was given way up high, right behind the top of the shoulder.; Very sore arm, painful to lift the arm; A spontaneous report was received from a reporter (consumer) concerning a concerning  female patient of unspecified age , who received Moderna's COVID-19 vaccine (mRNA-1273) and for the patient, second injection was given way up high, right behind the top of the shoulder and very sore arm/painful to lift the arm.  The patient's medical history was not provided .Concomitant medications were not provided.  On an unspecified date, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (Lot/batch: unknown) for prophylaxis of COVID-19 infection.   On an unspecified date, second injection was given way up high, right behind the top of the shoulder and patient experienced event very sore arm and painful to lift the arm .  Laboratory details was not provided . Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.    At the time of report, outcome of events incorrect route of product administration, vaccination site pain was resolved.; Reporter's Comments: This report refers to a case of incorrect route of product administration for mRNA-1273 (lot # unknown) with reported event of vaccination site pain.; Sender's Comments:  MOD-2021-038934:Reporter's Husband MOD-2021-038496:Reporter's Friend MOD-2021-038840:Reporter's Friend
Very sore dead  arm. Left tricep and left deltoid experience moderate to significant pain while in motion.; Very sore dead  arm. Left tricep and left deltoid experience moderate to significant pain while in motion.; This is a spontaneous report from a contactable consumer (patient). A 48-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EL3302, Expiration Date: not reported), via an unspecified route of administration, administered in left arm on 12Jan2021 at 14:00 (at the age of 48 years old) as first dose, single for COVID-19 immunisation. The facility it was administered was reported to be "other". Patient has no other medical history and has no known allergies. The patient did not receive any other vaccines in 4 weeks and no other medications in two weeks. Prior to vaccine the patient was not diagnosed with COVID-19. On13Jan2021 at 08:00 AM, the patient experienced very sore "dead" arm; Left tricep and left deltoid experience moderate to significant pain while in motion. No treatment was received for the adverse event. Since vaccination, the patient has not been tested for COVID-19. Outcome of the events was not recovered. The patient received second dose of BNT162B2 (lot number: EL9264) via an unspecified route of administration, administered in left arm on 02Feb2021.  No follow-up attempts are possible. No further information is expected.
I had a large lump under right arm pit, also had red on left arm, doctor said she felt it may have been a pre-existing cyst that may have been in reaction to the vaccine.
Systemic: Dizziness / Lightheadness-Medium, Additional Details: The patient claimed for dizziness right after receiving 1st dose of COVID vaccine. Called 911, but the patient refused to be transported via ambulance. The patient stayed in the store for the total of 30 minutes by sitting on a chair until her condition got better.
Stabbing pain starting head and rotating body sites, behind my eye, then in my joints elbow, knee, pins needle stabbing intensity, aching tired fever, arm unable to move for 1 week, stabbing pins and needles rotating paint stays in one area for a minute to 30 minutes or so then rotates ro a knew area, then reoccured at the beginning of menstrual cycle    horrible on month one then less and less each month thereafter, now occasional stabbing pain
Systemic: Large swollen lump under arm on the ride side 10/5/2022-Mild, Additional Details: On 10/12/2022, the patient reported adverse effects has completely cleared out and she is not experiencing any pain or discomfort.
Large reddened and swollen area around injection site, warm to touch, large portion of back of arm improving slightly over the last few days.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Jul2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 43 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Paxlovid rebound. Symptoms returned worse after I completed. treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: Anti-viral details: Product-COVID 19 Treatment, Brand-Paxlovid, Treatment start date-03Jul2022, Treatment stop date-08Jul2022 and Indication-Treatment of COVID-19. Symptoms returned worse after I completed treatment. The patient had no known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Left eye become blood shot and dry; Left eye become blood shot and dry; Trouble focusing on screens and devices; Left eye is still very dry and can become strained after long periods of focus.; vaccine received same date: Influenza - Right Arm; vaccine received same date: Influenza - Right Arm; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 25Nov2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; influenza vaccine (INFLUENZA), on 25Nov2022 as dose 1, single (Batch/Lot number: unknown), in right arm for immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: DUPIXENT. Vaccination history included: Covid-19 vaccine (Dose 1; Manufacturer Unknown), for COVID-19 Immunization; Covid-19 vaccine (Dose 2; Manufacturer Unknown), for COVID-19 Immunization; Covid-19 vaccine (Dose 3 (Booster); Manufacturer Unknown), for COVID-19 Immunization. The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 25Nov2022, outcome "unknown" and all described as "vaccine received same date: Influenza - Right Arm"; OCULAR HYPERAEMIA (non-serious), DRY EYE (non-serious) all with onset 26Nov2022, outcome "recovering" and all described as "Left eye become blood shot and dry"; ASTHENOPIA (non-serious) with onset 26Nov2022, outcome "not recovered", described as "Left eye is still very dry and can become strained after long periods of focus."; VISION BLURRED (non-serious) with onset 26Nov2022, outcome "recovering", described as "Trouble focusing on screens and devices". Therapeutic measures were not taken as a result of ocular hyperaemia, dry eye, vision blurred, asthenopia.  Additional information: Left eye become blood shot and dry. Trouble focusing on screens and devices. No fluid discharge. Took 3 days to partially recover to light pink sclera. Left eye is still very dry and can become strained after long periods of focus. No COVID prior vaccination, No COVID tested post vaccination, No treatment adverse event.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Bilateral lower extremity numbness; Tingling; Foot pain; This is a spontaneous report from a contactable nurse (patient). A 44-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EJ1685), via an unspecified route of administration on the left arm, on 22Dec2020, at single dose, for covid-19 immunization. The patient has no medical history. Concomitant medication included ibuprofen. The patient received the vaccine on 22Dec2020 at the hospital. The patient was not diagnosed with COVID-19 prior vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 30Dec2020 18:00 sudden onset of bilateral lower extremity numbness, tingling, and foot pain. These continued to present day. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received gabapentin as treatment for these adverse events. At the time of the report, the patient had not recovered from the adverse events. The patient has not been COVID-tested post-vaccination.
chronic inflammation, neuromuscular pain, neurological symptoms, weakness. vision changes, EBV and HHV reactivation, burning in tissues, burning around breast implants, gout type pain n fingers, cognitive dysfunction, high anxiety, hair loss, heavy acid reflux and stomach problems, cough, sinus pain, swollen lymph nodes, pelvic/vaginal cysts, post exertional malaise, arm pain resulting in frozen shoulder and cortisone injection, headaches, some hearing loss, swelling in calves, ankles and feet.  These began slowly after second injection on 2/6/21 and still continue to this date.   Was hospitalized Sept. 8-12 with colitis and sepsis and diagnosed with C-diff after taking antibiotic to treat vaginal cysts.
PATIENT RECIEVED INJECTION 1:00 PM, DIDN'T EXPIERENCE ANY SYMPTOMS WITHIN THE FIRST 15 MINS AFTER RECIEVING INJECTION.  ONE HOUR AFTER INJECTION FELT CHILLS ALL THROUGHT HER BODY. ABOUT 3 PM PATIENT NOTICED AFTER STANDING UP HER LEGS FELT LIKE RUBBER AND WERE REALLY WEAK.  TOOK A COUPLE STEPS FELT EXTREMELY DIZZY.  PATIENT STILL HAS DIZZINESS TO THIS DAY AS WELL AS NAUSEA AND RINGING IN HER EARS.
It was around 4 o'clock and got up and got up and was extremely tired and had fatigue with achiness and the next day I woke up stuffy with a little sore throat. I was not aware I had an exposure and I was waiting thinking I didn't need to test to early but decided to take a test anyway and it was positive with a COVID-19 home test. That was on a Friday that I tested positive and my daughter is a Physician assistant and she ordered the PAXLOVID for me and on Sunday I was still having symptoms and Monday I was feeling better. I tested again on Tuesday and I was negative.
Arm was a little sore; flu-like symptoms; headache; body aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was a little sore), INFLUENZA LIKE ILLNESS (flu-like symptoms), HEADACHE (headache), MYALGIA (body aches) and CHILLS (chills) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm was a little sore), INFLUENZA LIKE ILLNESS (flu-like symptoms), HEADACHE (headache), MYALGIA (body aches) and CHILLS (chills). At the time of the report, PAIN IN EXTREMITY (Arm was a little sore), INFLUENZA LIKE ILLNESS (flu-like symptoms), HEADACHE (headache), MYALGIA (body aches) and CHILLS (chills) outcome was unknown.            Concomitant medication was not provided Treatment information was not provided  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable   This case was linked to MOD-2021-071143 (Patient Link).
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 13-NOV-2013, the patient was vaccinated with PNEUMOVAX23 (0.5 ml) with lot # 0217AE and expiry date 22-AUG-2013, via intramuscular route. Additional information has been requested.
Arm is red, blotchy, warm at site of immunization starting yesterday. Tenderness/soreness was since shot was given. Right upper arm - multiple raised erythematous areas with one central red papule, very warm to touch, tender to palpation.
Headache; very sore joints; so weak had trouble walking; so weak had trouble walking; went to bed night of vaccine didn't get up till Sat morning; This is a spontaneous report from a contactable consumer (patient). A 79-years-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number Unknown), dose 2 via an unspecified route of administration, administered in right arm, on 25Feb2021 at 12:15pm (at the age of 79 years old) as single dose, for COVID-19 immunization. Facility where the most recent COVID-19 vaccine was administered was reported as Public Health Clinic/Veterans Administration. Medical history included allergies to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was receiving other medications within 2 weeks of vaccination however they were not provided. The patient received dose 1 of BNT162b2 (Lot number EL-9262) in right arm. The patient did not receive any other vaccines within 4 weeks prior to the BNT162b2 vaccine. On 25Feb2021 at 18:00 (6:00pm), the patient experienced headache, very sore joints, so weak had trouble walking and "went to bed night of vaccine didn't get up till sat morning". Treatment was not received for the events. Since the vaccination, the patient has not been tested for COVID-19. The clinical outcome of the events headache, very sore joints, so weak had trouble walking and "went to bed night of vaccine didn't get up till sat morning" was recovering.   The batch/lot numbers for the vaccine, PFIZER-BIONTECH COVID-19 mRNA VACCINE, were not provided and will be requested during follow up.
Pt. experienced symptoms of fever, chills, felt cold the night the vaccine was administered. Woke up in middle of night and husband had to warm her up w/ blankets. Only lasted for about 3 min.
Heart rate went up and went back to normal; Went to sleep and his heart started pounding and it woke him up; This spontaneous case was reported by a consumer and describes the occurrence of Heart rate went up and went back to normal and PALPITATIONS in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jul-2021, the patient experienced Heart rate went up and went back to normal and PALPITATIONS. At the time of the report, Heart rate went up and went back to normal and PALPITATIONS was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.  Patient stated everything was fine now.   Most recent FOLLOW-UP information incorporated above included On 08-Sep-2021 AE Outcome updated.
Vaccine was administered 9/19/2022, but use by date was on 9/17/2022
Pt reported to briefly lose consciousness and stated that his vision changed.  Pt did not fall completely from chair.  Pt was gently lowered to the ground.   Pt was alert and oriented x 3 and vision restored while lying on the ground.  Patient was given water but then when he sat up, he soon became unconscious again and again was gently lowered to the floor.  Regurgitated/ spit out the water.  After initial confusion, was alert and oriented again.
Got the COVID-19 vaccine shot and was COVID positive the day after; Got the COVID-19 vaccine shot and was COVID positive the day after; This is a spontaneous report from a contactable consumer (patient) via Pfizer sponsored program IBCC (Inbound Call Center for HCPs). A 61-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3248, expiration date not reported), via an unspecified route of administration on 09Jan2021 at single dose for COVID-19 immunization. Medical history included high blood pressure and high cholesterol. Concomitant medication included hydrochlorothiazide, lisinopril (LISINOPRIL HCTZ), atorvastatin. It was reported that the patient got the COVID-19 vaccine shot last Saturday (09Jan 2021) and was COVID positive on Sunday (10Jan2021), the day after. Outcome of the events was unknown.
This case was reported by a consumer (subject) and described the occurrence of throwing up in a 61-year-old female subject who was vaccinated with influenza vaccine unspecified (manufacturer unspecified). A physician or other health care professional has not verified this report. Concurrent medical conditions included systemic lupus erythematosus. Co-suspect medication included BELIMUMAB solution at 120 mg every 28 days. The subject started BELIMUMAB on 30 July 2013 and her most recent infusion was 11 October 2013. On 11 October 2013 the subject received a dose of influenza vaccine unspecified (unknown, unknown arm) and an infusion of BELIMUMAB. In 12 October 2013, 1 day after vaccination with influenza vaccine unspecified and her most recent infusion of BELIMUMAB, the subject experienced throwing up, feeling weak, dizziness, injection site redness and injection site swollen. The subject reported that she received her BELIMUMAB infusion and influenza vaccine unspecified on 11 October 2013 and became "ill throwing up and feeling weak and dizzy all weekend". The subject stated that "the arm where she received the flu vaccine became bright red and swollen." At the time of reporting the outcome of the events was unspecified. Follow-up information received from the consumer (subject) on 04 November 2013. The subject reported that she never went to her physician for "this experience". She denied authorization to contact her physician.
patient went into the store to receive a shingles shot and was given a COVID shot. Patient was already fully vaccinated with the Moderna and had received her second shot in April. Patient given a COVID shot.
This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got the 1st dose of the Moderna shot on 5Jan2021/missed correct interval inter dosis) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037152011) for COVID-19 vaccination. No Medical History information was reported. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got the 1st dose of the Moderna shot on 5Jan2021/missed correct interval inter dosis). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got the 1st dose of the Moderna shot on 5Jan2021/missed correct interval inter dosis) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication history not provided. Treatment information was unknown.
Myalgia body aches; tired Narrative:  OTC Aleve as needed  Other Relevant History:
Information has been received from a nurse practitioner concerning her 7 year old daughter who was vaccinated with two doses of VARIVAX (Merck). On unknown date, the patient developed a mild case of chicken pox. The patient was seen by the nurse practitioner. At the time of reporting, the patient's a mild case of chicken pox persisted. Additional information has been requested.
Patient woke up in the morning with Hives. She has not been around anything new other than the flu vaccination yesterday. This is the first time she had an allergic reaction after a flu vaccine.